Amyloid A amyloidosis on medullary sponge kidney in a 28-year-old male with gout: A case report and literature review.
amyloidosis
gout
hyperuricemic nephropathy
medullary sponge kidney
proteinuria
Journal
International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
revised:
20
10
2022
received:
31
08
2022
accepted:
23
10
2022
pubmed:
9
11
2022
medline:
31
1
2023
entrez:
8
11
2022
Statut:
ppublish
Résumé
Amyloidosis is a large group of diseases that occur through misfolding of extracellular proteins that accumulate in tissues and organs. Gout is the most common inflammatory arthritis worldwide and starts with the crystallization of uric acid within the joints and soft tissues. Although gouty arthritis is accompanied by inflammation, AA amyloidosis is rarely seen in patients with gout. Here we present a case of AA amyloidosis on the medullary sponge kidney in a 28-year-old man with gout. Our case had been diagnosed with gout 3 years previously, and his older brother was also diagnosed with early-onset gout. As a result of the hyperuricemic nephropathy clinic and familial history, a whole gene sequence analysis was performed on the HPRT1 gene and UMOD gene, but no pathogenic changes were detected. Renal ultrasound revealed a bilateral medullary sponge kidney and amyloidosis was detected in the renal needle biopsy performed for the etiology of proteinuria. In our literature review, we found 16 cases in which gout was accompanied by AA amyloidosis. We present a 17th case and compare it with the other 16 cases.
Identifiants
pubmed: 36346163
doi: 10.1111/1756-185X.14489
doi:
Substances chimiques
Uric Acid
268B43MJ25
Types de publication
Review
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
379-382Informations de copyright
© 2022 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Références
Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380-390.
Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458-3471.
Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos J. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014;6:369-377.
Lachmann HJ, Goodman HJB, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361-2371.
Talbott JH, Terplan KL. The kidney in gout. Medicine (Baltimore). 1960;39:405-467.
Talbott JH. Gout. 3rd ed. Grune and Stratton; 1967:95-96.
Levo Y, Shalev O, Rosenmann E, Eliakim M. Gout and amyloidosis. Ann Rheum Dis. 1980;39(6):589-591.
Rubinow A, Sonnenblick M. Amyloidosis secondary to polyarticular gout. Arthritis Rheum. 1981;24(11):1425-1427.
Lens XM, Rosello R, Montoliu J, et al. Amyloidosis secondary to gout. J Rheumatol. 1985;12(5):1024-1026.
Jacobelli S, Vial S, Rosenberg H, Benson MD, Scheinberg MA. Amyloidosis secondary to gout. Identification with a monoclonal antibody to amyloid protein A. Clin Rheumatol. 1988;7(4):534-537.
Guma M, Bayes B, Bonet J, Olive A. Gout and secondary amyloid. Clin Rheumatol. 1999;18(1):54-55.
Vernerová Z, Rychlík I, Brunerova L, Dvorakova L, Pavelková A, Sebesta I. An unusual cause of renal amyloidosis secondary to gout-the first description of familial occurrence. Nucleosides Nucleotides Nucleic Acids. 2006;25:1305-1308.
Azzam A, Balasubramaniam R, Safa S, McIvor C, Mollee P. Malabsorption secondary to gout-induced amyloidosis. ACG Case Rep J. 2017;4(1):e32.
Ter Borg EJ, Wegewijs MA, de Bruin P. Gout and AA amyloidosis: a case report and review of the literature. J Clin Rheumatol. 2017;23(4):233-234.
Brunger AF, Nienhuis HLA, van Rheenen RWJ, et al. Obesity-induced AA amyloidosis: a diagnosis of exclusion. Int J Clin Rheumatol. 2020;15(2):26-34.
Gromova MA, Tsurko VV. Gout and AA-amyloidosis: a case-based review. Mediterr J Rheumatol. 2021;32(1):74-80.
Bell S, Kolobova I, Crapper L, Ernst C. Lesch-Nyhan syndrome: models, theories, and therapies. Mol Syndromol. 2016;7(6):302-311.
Gong K, Xia M, Wang Y, et al. Autosomal dominant tubulointerstitial kidney disease genotype and phenotype correlation in a Chinese cohort. Sci Rep. 2021;11(1):3615.
Sevoyan MK, Sarkisian TF, Beglaryan AA, Shahsuvaryan GR, Armenian HK. Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia. Med Princ Pract. 2009;18(6):441-446.
Akoglu H, Dede F, Gonul II, Piskinpasa S, Odabas AR. Coexistence of medullary sponge kidney and renal AA amyloidosis in a patient with nephrotic range proteinuria. J Natl Med Assoc. 2010;102(3):247-249.